Tumour model

Sp2/0-Ag14

B cell hybridoma
SyngeneicIn vitro

Model characteristics

Organism
Mouse
Tissue of origin
Blood
Pathology
B cell hybridoma
Model type
In vitro, Syngeneic
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Human
Blood
Sezary syndrome (aggressive form of cutaneous T-cell lymphoma)
XenograftIn vitro
Mouse
Blood
SyngeneicIn vitro
Human
Blood
Plasma Cell Leukemia
XenograftIn vitro
Human
Blood
Burkitt lymphoma
XenograftIn vitro
Human
Blood
Childhood T acute lymphoblastic leukemia
XenograftIn vitro

EGG

Mouse
Blood
Leukemia
SyngeneicIn vitro